419688
Medtronic Attain Ability OTW Cardiac Vein Pacing Lead, 88cm
$649.00
box of 1
Out of stock
Expiration:
Expired
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
We currently do not have this item in stock, but we can email you as soon as it is available!
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in-date item only.
Medtronic Monosof black 18" C-13 cutting
$1.00 packets
Medtronic Maxon green 30" GS-11 Heavy Body Reverse Cutting
$215.00 box of 36
Medtronic Polysorb undyed 30" C-14 cutting
$5.00 packets
Medtronic Biosyn undyed 30" GS-22 taper
$89.00 box of 36
Medtronic Polysorb undyed 36" GS-25 taper
$4.00 packets
Medtronic Surgipro blue 30" GS-22 taper
$3.50 packets
Description
Attain Ability OTW
REF 4196
Dexamethasone Acetate (Steroid) Eluting, Dual Electrode, Transvenous, Over The Wire
- Compatibility: IS-1
- OTW Delivery
- Stylet Delivery
- Distal Lead Diameter: 4.6F
- Proximal Lead Diameter: 4.0F
- Tip Seal
- Distal Shape: Angled
- Fixation: Dual Canted
- Polarity: Bipolar
- Electrode Separation: 21mm
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Unit | box of 1 |
- FDA Product Code: DTB OJX
- FDA Product Code Name: permanent pacemaker Electrode / Drug eluting permanent left ventricular (lv) pacemaker electrode
- GMDN Term Code: 60910
- GMDN Term Name: Coronary venous pacing lead
- GMDN Term Description: An implantable flexible wire with an electrode, insulated with non-conductive material except at its ends, which serves as an electrical conductor to transmit pacing impulses from an implanted cardiac resynchronization therapy (CRT) pulse generator to the left ventricle of the heart. It may also transmit electrical responses from the heart back to the pacemaker; it is not intended to conduct defibrillation impulses. The electrode end is introduced into a cardiac vein through transvenous approach via the coronary sinus. It is typically impregnated with a steroid (e.g., dexamethasone) intended to elute into the tissues to reduce inflammation.
